###begin article-title 0
###xml 20 23 <span type="species:ncbi:10116">rat</span>
Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids
###end article-title 0
###begin p 1
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 681 682 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1074 1075 1073 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1365 1366 1364 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 7 10 <span type="species:ncbi:10116">rat</span>
###xml 346 350 <span type="species:ncbi:10116">rats</span>
###xml 403 407 <span type="species:ncbi:10116">rats</span>
###xml 422 426 <span type="species:ncbi:10116">rats</span>
###xml 977 981 <span type="species:ncbi:10116">rats</span>
###xml 1255 1258 <span type="species:ncbi:10116">rat</span>
###xml 1341 1344 <span type="species:ncbi:10116">rat</span>
In the rat, the sexual dimorphism in growth hormone release is driven by sex steroids, and is suggested to result mainly from differences in somatostatin (SOM) release patterns from the median eminence. We studied the effect of gonadal steroids on SOM peptide-containing cells in the periventricular nucleus (PeVN) of ovariectomized (OVX) female rats, and compared these data with data from intact male rats. Adult female rats were treated with estradiol (E2) and/or progesterone (P), 3 months (long-term) or 2 weeks (short-term) after ovariectomy (OVX). Perfusion-fixed brains were sliced and stained, and the number of SOM-immunoreactive (-ir) cells and total SOM-ir area (in mum2) were determined using computer assisted analysis. SOM-ir cells in the PeVN showed a very characteristic rostro-caudal distribution and localization in relation to the third ventricle. Both the number of SOM-ir cells and total SOM-ir area in the PeVN were higher in male compared to OVX female rats. Neither the number of SOM-ir cells, nor the total SOM-ir area in the PeVN was affected by E2 or P treatment alone. Treatment with both gonadal steroids, however, did increase total SOM-immunoreactivity. This study is the first to describe SOM cell distribution within the rat PeVN in great detail. A clear sex difference exists in SOM peptide content in the rat PeVN. In addition, E2 and P may act synergistically to affect SOM cells in the female PeVN, suggesting that both gonadal steroids may be involved in the generation of the typical feminine SOM release pattern.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1987</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1979</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">1998</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1987</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1979</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">1998</xref>
###xml 7 10 <span type="species:ncbi:10116">rat</span>
In the rat, growth hormone (GH) release patterns are sexually dimorphic (Clark et al. 1987; Eden 1979; Gatford et al. 1998). In males, GH secretion is characterized by regular high amplitude pulses occurring at approximately 3-h intervals, and low baseline levels. Females exhibit irregular low amplitude GH levels and higher baseline levels than males (Clark et al. 1987; Eden 1979; Gatford et al. 1998).
###end p 4
###begin p 5
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">1981</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1997</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">1988</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">1987</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">1984</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">1990</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">1981</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">1985</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">1991</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">2004</xref>
###xml 436 440 <span type="species:ncbi:163112">Ling</span>
Release of GH from the pituitary is mainly regulated by the interplay between the stimulating effects of GH-releasing hormone (GHRH), synthesized in cells of the arcuate nucleus of the hypothalamus (ARC), and the inhibiting effects of somatostatin (SOM), synthesized in cells of the periventricular nucleus of the hypothalamus (PeVN) (Critchlow et al. 1981; Gillies 1997; Katakami et al. 1988; Praputpittaya et al. 1987; Tannenbaum and Ling 1984; Tannenbaum et al. 1990; Terry and Martin 1981; Urman et al. 1985; Zeitler et al. 1991). Also ghrelin is found to stimulate GH release and ghrelin-producing cells in the hypothalamus may stimulate GHRH cells in the ARC (Korbonits and Grossman 2004). However, the exact role, as well as the impact of ghrelin in the hypothalamic regulation of GH secretion remains uncertain.
###end p 5
###begin p 6
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">1981</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">1985</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">1984</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">1990</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">1993</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">1991</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">1985</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1991</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1996</xref>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">1985</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1985</xref>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1991</xref>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">1985</xref>
###xml 1005 1009 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">1984</xref>
###xml 1029 1033 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">1990</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">1991</xref>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1997</xref>
###xml 1379 1383 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">1999</xref>
###xml 1403 1407 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">1990</xref>
###xml 166 170 <span type="species:ncbi:10116">rats</span>
###xml 341 345 <span type="species:ncbi:163112">Ling</span>
###xml 804 808 <span type="species:ncbi:10116">rats</span>
###xml 1000 1004 <span type="species:ncbi:163112">Ling</span>
The typical masculine and feminine GH secretion patterns are most likely the direct result of differences in SOM and GHRH release patterns between the sexes. In male rats, SOM is released in regular pulses with maximal levels during a GH trough and minimal levels during a GH peak (Kasting et al. 1981; Plotsky and Vale 1985; Tannenbaum and Ling 1984; Tannenbaum et al. 1990, 1993; Zeitler et al. 1991). In females, SOM release is thought to be more constant, and at a level in-between the maximum and minimum levels that are observed in males (Clark and Robinson 1985; Painson and Tannenbaum 1991), although relatively small and irregular SOM peaks have also been reported (Estupina et al. 1996). GHRH release from the ME on the other hand, appears to be pulsatile in both sexes, albeit regular in male rats, with peak levels occurring during the SOM troughs, and irregular in females (Clark and Robinson 1985; Jansson et al. 1985; Painson and Tannenbaum 1991; Plotsky and Vale 1985; Tannenbaum and Ling 1984; Tannenbaum et al. 1990; Zeitler et al. 1991). Thus, with respect to the bimodal hypothalamic regulation of GH release, differences in SOM release are most pronounced between the sexes. Therefore, the sexual dimorphism in GH release has been suggested to result mainly from differences in SOM release patterns from the median eminence (ME) (Gillies 1997; Muller et al. 1999; Tannenbaum et al. 1990).
###end p 6
###begin p 7
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1984</xref>
###xml 118 123 118 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1987a</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">b</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1992</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">1989</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">1988</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">1991</xref>
###xml 495 496 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 649 650 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1996</xref>
###xml 889 890 889 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1992</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">1988</xref>
###xml 947 951 947 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">1990</xref>
###xml 1102 1103 1102 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1153 1157 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1996</xref>
###xml 1167 1171 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">1994</xref>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">1983</xref>
###xml 1207 1211 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">1991</xref>
###xml 1234 1235 1234 1235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1315 1316 1315 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1543 1547 1543 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">1994</xref>
###xml 231 235 <span type="species:ncbi:10116">rats</span>
###xml 477 481 <span type="species:ncbi:10116">rats</span>
###xml 685 689 <span type="species:ncbi:10116">rats</span>
###xml 1009 1012 <span type="species:ncbi:10116">rat</span>
###xml 1385 1388 <span type="species:ncbi:10116">rat</span>
As GH release patterns are highly dependent on the gonadal steroidal milieu (Jansson et al. 1984; Jansson and Frohman 1987a; b), the synthesis and release of SOM may also be affected by gonadal steroids. Indeed, castration of male rats decreases both hypothalamic SOM mRNA levels and SOM peptide content, which can be restored by treatment with testosterone (Bethea et al. 1992; Chowen-Breed et al. 1989; Murray et al. 1999; Werner et al. 1988; Zorilla et al. 1991). In female rats, estradiol (E2) affects both hypothalamic SOM mRNA and peptide levels, although conflicting results have been reported: Neither ovariectomy (Murray et al. 1999), nor E2 treatment of ovariectomized (OVX) rats (Estupina et al. 1996) affects the total hypothalamic SOM peptide content. In contrast, SOM mRNA levels in the PeVN also decrease following OVX, but this reduction can be reversed by treatment with E2 (Bethea et al. 1992; Werner et al. 1988; Zorilla et al. 1990). In addition, it is reported that in the cycling female rat hypothalamic SOM content and SOM release from the ME fluctuate concurrently with plasma E2 levels during the estrous cycle (Estupina et al. 1996; Freeman 1994; Knuth et al. 1983; Zorilla et al. 1991). This suggests that E2 may indeed affect hypothalamic SOM synthesis and release. The precise role of E2 in the regulation of hypothalamic SOM system activity in the female rat remains to be established. Also progesterone (P), which has a direct feedback action at the brain level to control the female reproductive cycle (Freeman 1994), may be involved in the regulation of the typical feminine SOM release pattern. To date, the role of progesterone in the hypothalamic regulation of GH release has not been studied at all.
###end p 7
###begin p 8
###xml 120 124 <span type="species:ncbi:10116">rats</span>
###xml 269 273 <span type="species:ncbi:10116">rats</span>
In the present study, we first compared the distribution of SOM cells within the PeVN between adult OVX female and male rats in detail. In addition, we examined the effects of gonadal steroids on the number of SOM cells and on SOM peptide content in the PeVN of female rats.
###end p 8
###begin title 9
Methods
###end title 9
###begin title 10
Animals
###end title 10
###begin p 11
###xml 372 373 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#160;</italic>
###xml 423 424 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 454 455 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 14 25 <span type="species:ncbi:10116">Wistar rats</span>
A total of 46 Wistar rats (8 adult males and 38 adult females) (Harlan, Horst, The Netherlands) were pair-housed in a room with controlled lighting (12L:12D, lights on at 04.00 h), temperature (23degreesC), and humidity (70%). Standard pelleted food and tap water were available ad libitum. A dim red light remained on at all times, including the dark period. Males were 4 months old and females were 11-12 weeks (group I, n = 32) or 16 weeks (group II, n = 6) old on arrival. All experiments were carried out in accordance with the "Principles of laboratory animal care" of the NIH and the Wageningen University Animal Ethics Committee approved all experiments.
###end p 11
###begin title 12
Experimental design
###end title 12
###begin p 13
###xml 407 408 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 451 452 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 652 653 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 670 671 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 678 679 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 728 729 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 746 747 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 750 751 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 11 15 <span type="species:ncbi:10116">rats</span>
###xml 548 552 <span type="species:ncbi:10116">rats</span>
All female rats underwent bilateral ovariectomy (OVX) at 12 weeks of age (group I) or at the age of 18 weeks (group II) under gas anesthesia with a mixture of Isoflurane (Isoflo; Abbott Laboratories Ltd, England) and oxygen (3:1 ratio). Three months (3 mo) after OVX, the females of group I ("long-term") received a subcutaneous (s.c.) injection with estradiol benzoate (EB; 12.5 mug/0.1 ml cottonseed oil; n = 16) or with 0.1 ml cottonseed oil only (n = 16) between 08:30 and 09:00 h on two consecutive days (treatment day 1 and 2). On day 3, the rats received an s.c. injection with either progesterone (P; 0.25 mg/0.1 ml cottonseed oil) ("OVX + P", n = 8 and "OVX + E2 + P", n = 8) or with 0.1 ml cottonseed oil only ("OVX", n = 8 and "OVX + E2", n = 8) at 11:00 h.
###end p 13
###begin p 14
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 389 393 <span type="species:ncbi:10116">Rats</span>
As results obtained from previous studies in our lab suggested that the time period of steroid deprivation following OVX may change the sensitivity of SOM cells to E2 feedback (unpublished data), an additional group of OVX females was included (group II, "short-term") to compare the effects of EB treatment between short-term and long-term OVX animals on hypothalamic SOM peptide levels. Rats in group II ("short-term") received the two s.c. injections with EB (treatment day 1 and 2) and an s.c. injection with oil (treatment day 3), 2 weeks after OVX.
###end p 14
###begin p 15
###xml 179 182 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 554 558 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">1982</xref>
###xml 40 44 <span type="species:ncbi:10116">rats</span>
###xml 278 282 <span type="species:ncbi:10116">Rats</span>
On treatment day 3, all female and male rats were perfused just prior to dark onset, i.e. between 15:30 and 16:00 h. Prior to perfusion, animals were given an overdose of Nembutal(R) anesthesia (CEVA sante animale B.V., Maassluis, The Netherlands; 1.5 ml/kg body weight; i.p.). Rats were perfused transcardially with 200 ml (females) or 300 ml (males) saline followed by 300 ml (females) or 400 ml (males) Somogyi fixative (2% paraformaldehyde in 0.1 M phosphate buffer pH 7.4 with 0.1% glutaraldehyde and 0.2% saturated picric acid) (Somogyi and Takagi 1982). Brains were removed from the skull immediately after perfusion and post-fixed in the same fixative for 25 h at 4degreesC. Tissue blocks containing the hypothalamus were sliced into coronal sections of 40 mum using a Vibratome (Vibratome Company, St Louis, USA; series 1500), distributed into three series of alternating sections and stored in 0.1 M Tris buffer containing 0.9% NaCl (TBS, pH 7.4) at 4degreesC until immunocytochemistry.
###end p 15
###begin title 16
Immunocytochemistry
###end title 16
###begin p 17
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">1994</xref>
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">1989</xref>
###xml 1173 1174 1167 1168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1175 1176 1169 1170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 374 380 <span type="species:ncbi:9986">rabbit</span>
###xml 663 667 <span type="species:ncbi:9925">goat</span>
###xml 673 679 <span type="species:ncbi:9986">rabbit</span>
One series of sections (one-third of the total hypothalamus) of each animal was stained for SOM peptide using free-floating immunocytochemistry techniques (Van der Beek et al. 1994). Sections were pretreated with 3% H2O2 (Merck, Darmstadt, Germany) in TBS for 30 min, followed by extensive washing with TBS. Subsequently, sections were incubated with the primary polyclonal rabbit antibody raised against SOM peptide (Somaar 080289, NIH, Amsterdam, The Netherlands; final dilution 1:30,000) (Buijs et al. 1989), diluted in supermix (TBS containing 0.5% Triton-X-100 and 0.25% gelatin) for one night at 4degreesC. This was followed by incubation with biotinylated goat anti-rabbit Immunoglobulin G (GaR-bio; Vector Laboratories; Burlingame, CA; USA, 1:500 in supermix) for 1.5 h at room temperature, and Avidin-Biotin Complex-elite (ABC; Vector Laboratories; final dilution 1:1,500 in supermix) for 1.5 h at room temperature. Between incubation steps, sections were thoroughly washed with TBS. Immunoreactivity for SOM was visualized by incubation with 0.05% 3,3'-diaminobenzidine (DAB; Sigma Chemical Company, St Louis, MO, USA) in TBS containing 0.1% imidazole and 0.03% H2O2 for 14.5 min.
###end p 17
###begin p 18
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1992</xref>
Stained sections were mounted on albumin-coated slides, dried, dehydrated and coverslipped in DEPEX (BDH Laboratory Supplies, Poole, England). SOM-immunoreactive (SOM-ir) neurons in the PeVN were counted using computer assisted image analysis (Scion Image Beta, version 4.02; Scion Corporation, Maryland, USA) following background correction (Bethea et al. 1992).
###end p 18
###begin title 19
Selection of the PeVN area
###end title 19
###begin p 20
###xml 622 626 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">1986</xref>
###xml 823 827 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">1986</xref>
###xml 971 975 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">1987</xref>
###xml 998 1002 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">1989</xref>
###xml 1051 1055 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1990</xref>
###xml 1073 1077 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">1986</xref>
###xml 1097 1101 1096 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">1989</xref>
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Images of the left side of the brain containing the PeVN (standardized to 9 images per rat brain) were captured using a microscope (50x magnification) with a digital black-and-white CCD camera (Sony, XC-77CE) connected to a computer. The nine consecutive sections (80 mum apart) containing the PeVN were selected using several criteria, including the shape of the third ventricle and the optic chiasm as well as the staining pattern. The first section of the PeVN included for analysis was the section in which the suprachiasmatic nucleus (SCN) first appeared (Plate 22 according to Paxinos and Watson (Paxinos and Watson 1986). The last section of the PeVN included for analysis was the last section before the ventral medial nucleus (VMN), containing dense SOM fiber staining, first appeared (Plate 26 Paxinos and Watson 1986). The total PeVN, defined as described above includes all periventricular SOM cells that have been shown to project to the ME (Ishikawa et al. 1987; Merchenthaler et al. 1989). In line with previous reports (Argente et al. 1990; Epelbaum et al. 1986; Willoughby et al. 1989) and for evaluation purposes only, the total length of the PeVN was divided into three rostro-to-caudal subregions: the anterior, medial, and posterior PeVN, referring to respectively PeVN sections 1-3, 4-6 and 7-9.
###end p 20
###begin p 21
For schematic camera lucida drawings of the PeVN, images were imported into Adobe Illustrator (version 8.0), a drawing program in which schematic drawings can be made by placing an empty layer over the image file. In this layer, immunoreactive neurons were marked and saved.
###end p 21
###begin title 22
Data analysis
###end title 22
###begin p 23
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1992</xref>
###xml 1110 1111 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1190 1191 1190 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1313 1314 1312 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1430 1431 1429 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1434 1440 1433 1439 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1705 1706 1704 1705 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1708 1709 1707 1708 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1747 1748 1746 1747 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1775 1776 1774 1775 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1785 1786 1784 1785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1792 1793 1791 1792 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1870 1875 1869 1874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 1925 1936 1924 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> black dots</italic>
###xml 1972 1973 1970 1971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1440 2078 1439 2076 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24">Automated image analysis of SOM cells in the PeVN. Densitometric analysis of SOM-ir cells in the PeVN using a defined threshold level (see text for details). Pictures of the whole PeVN were taken from sections defined as PeVN level 5 from one representative OVX&#160;+&#160;E<sub>2</sub> (<bold>a</bold>) and one representative male animal (<bold>c</bold>) (&#215;100 magnification). In <bold>b</bold> (OVX&#160;+&#160;E<sub>2</sub>) and <bold>d</bold> (male) all staining intensity above the defined threshold level is shown in <italic>black</italic> (using the automated image analysis system). Only<italic> black dots</italic> larger than 5&#160;pixels (i.e. 16.2&#160;&#956;m<sup>2</sup>) were considered as a positively stained cell by the image analysis system (measuring results not shown)</p>
###xml 1440 2078 1439 2076 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24">Automated image analysis of SOM cells in the PeVN. Densitometric analysis of SOM-ir cells in the PeVN using a defined threshold level (see text for details). Pictures of the whole PeVN were taken from sections defined as PeVN level 5 from one representative OVX&#160;+&#160;E<sub>2</sub> (<bold>a</bold>) and one representative male animal (<bold>c</bold>) (&#215;100 magnification). In <bold>b</bold> (OVX&#160;+&#160;E<sub>2</sub>) and <bold>d</bold> (male) all staining intensity above the defined threshold level is shown in <italic>black</italic> (using the automated image analysis system). Only<italic> black dots</italic> larger than 5&#160;pixels (i.e. 16.2&#160;&#956;m<sup>2</sup>) were considered as a positively stained cell by the image analysis system (measuring results not shown)</p></caption>
###xml 2078 2078 2076 2076 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="221_2008_1381_Fig1_HTML" id="MO6"/>
###xml 1434 2078 1433 2076 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="24">Automated image analysis of SOM cells in the PeVN. Densitometric analysis of SOM-ir cells in the PeVN using a defined threshold level (see text for details). Pictures of the whole PeVN were taken from sections defined as PeVN level 5 from one representative OVX&#160;+&#160;E<sub>2</sub> (<bold>a</bold>) and one representative male animal (<bold>c</bold>) (&#215;100 magnification). In <bold>b</bold> (OVX&#160;+&#160;E<sub>2</sub>) and <bold>d</bold> (male) all staining intensity above the defined threshold level is shown in <italic>black</italic> (using the automated image analysis system). Only<italic> black dots</italic> larger than 5&#160;pixels (i.e. 16.2&#160;&#956;m<sup>2</sup>) were considered as a positively stained cell by the image analysis system (measuring results not shown)</p></caption><graphic position="anchor" xlink:href="221_2008_1381_Fig1_HTML" id="MO6"/></fig>
Images of the left side of the brain containing the PeVN, covering the 9 consecutive PeVN sections as described above, were captured using a microscope (100x magnification) with a digital black-and-white CCD camera (Sony, XC-77CE) connected to a computer. Unilateral analysis was performed since no significant differences in SOM-immunoreactivity (-ir) and cell number within the PeVN were detected between the left and right side of the hypothalamus (unpublished results). Images were analyzed using an image analysis program (Scion Image Beta, version 4.02; Scion Corporation, Maryland, USA) applying gray level threshold discrimination (Bethea et al. 1992). By capturing each image at the same gray level, i.e. the average gray level of the entire image, a background correction was made. Subsequently, the gray level was used to determine the threshold for analysis by measuring true background (i.e. the gray level in an area that contained SOM-ir fibers, but no SOM-ir cell bodies) in a representative selection of all images. The threshold was calculated based on the mean true background gray value + 3x standard deviation, thus reducing the chance of false positive cell counts to P < 0.01. Using this threshold, the number of SOM-ir neurons was counted automatically. A cutoff size of 5 pixels (16.2 mum2) was used as a lower limit; excluding the possibility of including dendrites in the automated cell count (see Fig. 1). Fig. 1Automated image analysis of SOM cells in the PeVN. Densitometric analysis of SOM-ir cells in the PeVN using a defined threshold level (see text for details). Pictures of the whole PeVN were taken from sections defined as PeVN level 5 from one representative OVX + E2 (a) and one representative male animal (c) (x100 magnification). In b (OVX + E2) and d (male) all staining intensity above the defined threshold level is shown in black (using the automated image analysis system). Only black dots larger than 5 pixels (i.e. 16.2 mum2) were considered as a positively stained cell by the image analysis system (measuring results not shown)
###end p 23
###begin p 24
###xml 265 266 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 268 269 268 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 307 308 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 335 336 335 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 345 346 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 352 353 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 485 496 485 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> black dots</italic>
###xml 532 533 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Automated image analysis of SOM cells in the PeVN. Densitometric analysis of SOM-ir cells in the PeVN using a defined threshold level (see text for details). Pictures of the whole PeVN were taken from sections defined as PeVN level 5 from one representative OVX + E2 (a) and one representative male animal (c) (x100 magnification). In b (OVX + E2) and d (male) all staining intensity above the defined threshold level is shown in black (using the automated image analysis system). Only black dots larger than 5 pixels (i.e. 16.2 mum2) were considered as a positively stained cell by the image analysis system (measuring results not shown)
###end p 24
###begin p 25
###xml 264 265 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
The mean average number of neurons per section as well as the mean cumulative number of cells per animal (i.e. total SOM number of nine PeVN sections) was calculated for each group (mean +/- SEM). In addition to cell counts, we also analyzed the total area (in mum2) covered by SOM-immunoreactivity above threshold level using the same images and analysis program as described above. This measurement provides a reliable tool to estimate the amount of SOM peptide present in the PeVN and is independent of cell size. In general, SOM cell number and SOM-ir measurements showed a significant and very high correlation within individual animals in all groups, both males and females (data not shown).
###end p 25
###begin p 26
For statistical analysis, the total number of SOM-ir cells and total SOM-ir area, i.e. the sum of nine PeVN sections ("total PeVN"), were used. In addition to this, we analyzed the number of SOM-ir cells and SOM-ir area in the anterior, medial, and caudal part of the PeVN.
###end p 26
###begin p 27
###xml 687 688 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data were analyzed using the SPSS statistical analysis system (SPSS, Chicago, IL, USA). Oneway ANOVAs were used to compare both the total number of SOM-ir cells and total SOM-ir area (total PeVN and PeVN sub regions) between the male group and all female groups, and between the different gonadal steroid treatments within OVX female groups. In addition, separate Bonferroni Tests were used for post-hoc testing to compare both the number of SOM-ir cells and SOM-ir area between different gonadal steroid treatments in OVX females. To compare the effect of short-term versus long-term ovariectomy on the number of SOM-ir cells and SOM-ir area (total PeVN and PeVN sub regions), separate T-tests were used. Differences were considered to be significant when P < 0.05.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Rostro-caudal distribution of SOM cells within the PeVN
###end title 29
###begin p 30
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">1987</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 525 531 525 531 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 633 634 633 634 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 647 648 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 661 662 661 662 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 531 788 531 788 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">SOM cells in the PeVN. Photographs showing SOM immunoreactivity in the PeVN of a representative male (<bold>a</bold>) and OVX&#160;+&#160;E<sub>2</sub> female rat (<bold>b</bold>). Pictures of the <italic>right</italic> side of the ventricle were taken at a high magnification (&#215;400) from sections defined as PeVN level 5</p>
###xml 531 788 531 788 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31">SOM cells in the PeVN. Photographs showing SOM immunoreactivity in the PeVN of a representative male (<bold>a</bold>) and OVX&#160;+&#160;E<sub>2</sub> female rat (<bold>b</bold>). Pictures of the <italic>right</italic> side of the ventricle were taken at a high magnification (&#215;400) from sections defined as PeVN level 5</p></caption>
###xml 788 788 788 788 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="221_2008_1381_Fig2_HTML" id="MO1"/>
###xml 525 788 525 788 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="31">SOM cells in the PeVN. Photographs showing SOM immunoreactivity in the PeVN of a representative male (<bold>a</bold>) and OVX&#160;+&#160;E<sub>2</sub> female rat (<bold>b</bold>). Pictures of the <italic>right</italic> side of the ventricle were taken at a high magnification (&#215;400) from sections defined as PeVN level 5</p></caption><graphic position="anchor" xlink:href="221_2008_1381_Fig2_HTML" id="MO1"/></fig>
###xml 656 659 <span type="species:ncbi:10116">rat</span>
SOM immunoreactivity was found in cell bodies and fibers dispersed within a small zone just alongside the third ventricle in both males and females, as previously described (Ishikawa et al. 1987). Most cells within this region were darkly stained large neurons, frequently showing more than one immunoreactive dendrite extending from the cell body. Immunoreactivity within the cell was localized in the cytoplasm, resulting in a lighter stained central zone in the cell soma representing the unstained nuclear region (Fig. 2)Fig. 2SOM cells in the PeVN. Photographs showing SOM immunoreactivity in the PeVN of a representative male (a) and OVX + E2 female rat (b). Pictures of the right side of the ventricle were taken at a high magnification (x400) from sections defined as PeVN level 5
###end p 30
###begin p 31
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 125 128 <span type="species:ncbi:10116">rat</span>
SOM cells in the PeVN. Photographs showing SOM immunoreactivity in the PeVN of a representative male (a) and OVX + E2 female rat (b). Pictures of the right side of the ventricle were taken at a high magnification (x400) from sections defined as PeVN level 5
###end p 31
###begin p 32
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 868 874 868 874 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1026 1030 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 1044 1049 1044 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1102 1114 1102 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 1201 1202 1201 1202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1236 1239 1236 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">III</italic>
###xml 1257 1261 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o.c.</italic>
###xml 1276 1279 1276 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCN</italic>
###xml 874 1303 874 1303 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">SOM cell distribution in the PeVN. Camera lucida drawings of immunoreactive somatostatin cells throughout the PeVN of the adult rat. Cell bodies at the <italic>left</italic> (female) and <italic>right</italic> (male) side of the third ventricle are indicated by <italic>open circles</italic>. These are drawings of the nine successive PeVN sections of one representative OVX&#160;+&#160;E<sub>2</sub> and one representative male rat. <italic>III</italic> third ventricle; <italic>o.c.</italic> optic chiasm; <italic>SCN</italic> suprachiasmatic nucleus</p>
###xml 874 1303 874 1303 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">SOM cell distribution in the PeVN. Camera lucida drawings of immunoreactive somatostatin cells throughout the PeVN of the adult rat. Cell bodies at the <italic>left</italic> (female) and <italic>right</italic> (male) side of the third ventricle are indicated by <italic>open circles</italic>. These are drawings of the nine successive PeVN sections of one representative OVX&#160;+&#160;E<sub>2</sub> and one representative male rat. <italic>III</italic> third ventricle; <italic>o.c.</italic> optic chiasm; <italic>SCN</italic> suprachiasmatic nucleus</p></caption>
###xml 1303 1303 1303 1303 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="221_2008_1381_Fig3_HTML" id="MO2"/>
###xml 868 1303 868 1303 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="33">SOM cell distribution in the PeVN. Camera lucida drawings of immunoreactive somatostatin cells throughout the PeVN of the adult rat. Cell bodies at the <italic>left</italic> (female) and <italic>right</italic> (male) side of the third ventricle are indicated by <italic>open circles</italic>. These are drawings of the nine successive PeVN sections of one representative OVX&#160;+&#160;E<sub>2</sub> and one representative male rat. <italic>III</italic> third ventricle; <italic>o.c.</italic> optic chiasm; <italic>SCN</italic> suprachiasmatic nucleus</p></caption><graphic position="anchor" xlink:href="221_2008_1381_Fig3_HTML" id="MO2"/></fig>
###xml 1303 1309 1303 1309 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1419 1429 1419 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 1444 1453 1444 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bars</italic>
###xml 1463 1464 1463 1464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1473 1483 1473 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bars</italic>
###xml 1495 1510 1495 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">light gray bars</italic>
###xml 1524 1525 1524 1525 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1538 1552 1538 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark gray bars</italic>
###xml 1560 1564 1560 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bars</italic>
###xml 1590 1591 1588 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1706 1707 1704 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1812 1821 1810 1819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisks</italic>
###xml 1874 1875 1872 1873 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1902 1903 1900 1901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 1906 1910 1904 1908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hash</italic>
###xml 1938 1939 1936 1937 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1971 1977 1969 1975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 1998 1999 1996 1997 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2018 2023 2016 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cross</italic>
###xml 1309 2024 1309 2022 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Average number of SOM cells in the PeVN. Number of SOM-ir cells in the nine successive PeVN sections of male (<italic>black bars</italic>), OVX female (<italic>gray bars</italic>), OVX&#160;+&#160;E<sub>2</sub> female (<italic>white bars</italic>), OVX&#160;+&#160;P (<italic>light gray bars</italic>), and OVX&#160;+&#160;E<sub>2</sub>&#160;+&#160;P female (<italic>dark gray bars</italic>) rats. <italic>Bars</italic> represent means&#160;&#177;&#160;SEM. <italic>N</italic>&#160;=&#160;8 for each group. Overall testing revealed significant differences between male and female groups. Significant (<italic>P</italic>&#160;&lt;&#160;0.05) post hoc testing results for individual sections are indicated; males versus all female groups (<italic>asterisks</italic>) (PeVN sections&#160;1&#8211;3, 5&#8211;6, 8&#8211;9), males versus OVX&#160;+&#160;E<sub>2</sub> and OVX&#160;+&#160;P (PeVN section <italic>4</italic>) (<italic>Hash</italic>), males versus OVX, OVX&#160;+&#160;E<sub>2</sub>, and OVX&#160;+&#160;P (PeVN section 7) (<italic>circle</italic>), OVX versus OVX&#160;+&#160;E<sub>2</sub> (PeVN section 4) (<italic>cross</italic>)</p>
###xml 1309 2024 1309 2022 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">Average number of SOM cells in the PeVN. Number of SOM-ir cells in the nine successive PeVN sections of male (<italic>black bars</italic>), OVX female (<italic>gray bars</italic>), OVX&#160;+&#160;E<sub>2</sub> female (<italic>white bars</italic>), OVX&#160;+&#160;P (<italic>light gray bars</italic>), and OVX&#160;+&#160;E<sub>2</sub>&#160;+&#160;P female (<italic>dark gray bars</italic>) rats. <italic>Bars</italic> represent means&#160;&#177;&#160;SEM. <italic>N</italic>&#160;=&#160;8 for each group. Overall testing revealed significant differences between male and female groups. Significant (<italic>P</italic>&#160;&lt;&#160;0.05) post hoc testing results for individual sections are indicated; males versus all female groups (<italic>asterisks</italic>) (PeVN sections&#160;1&#8211;3, 5&#8211;6, 8&#8211;9), males versus OVX&#160;+&#160;E<sub>2</sub> and OVX&#160;+&#160;P (PeVN section <italic>4</italic>) (<italic>Hash</italic>), males versus OVX, OVX&#160;+&#160;E<sub>2</sub>, and OVX&#160;+&#160;P (PeVN section 7) (<italic>circle</italic>), OVX versus OVX&#160;+&#160;E<sub>2</sub> (PeVN section 4) (<italic>cross</italic>)</p></caption>
###xml 2024 2024 2022 2022 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="221_2008_1381_Fig4_HTML" id="MO3"/>
###xml 1303 2024 1303 2022 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="34">Average number of SOM cells in the PeVN. Number of SOM-ir cells in the nine successive PeVN sections of male (<italic>black bars</italic>), OVX female (<italic>gray bars</italic>), OVX&#160;+&#160;E<sub>2</sub> female (<italic>white bars</italic>), OVX&#160;+&#160;P (<italic>light gray bars</italic>), and OVX&#160;+&#160;E<sub>2</sub>&#160;+&#160;P female (<italic>dark gray bars</italic>) rats. <italic>Bars</italic> represent means&#160;&#177;&#160;SEM. <italic>N</italic>&#160;=&#160;8 for each group. Overall testing revealed significant differences between male and female groups. Significant (<italic>P</italic>&#160;&lt;&#160;0.05) post hoc testing results for individual sections are indicated; males versus all female groups (<italic>asterisks</italic>) (PeVN sections&#160;1&#8211;3, 5&#8211;6, 8&#8211;9), males versus OVX&#160;+&#160;E<sub>2</sub> and OVX&#160;+&#160;P (PeVN section <italic>4</italic>) (<italic>Hash</italic>), males versus OVX, OVX&#160;+&#160;E<sub>2</sub>, and OVX&#160;+&#160;P (PeVN section 7) (<italic>circle</italic>), OVX versus OVX&#160;+&#160;E<sub>2</sub> (PeVN section 4) (<italic>cross</italic>)</p></caption><graphic position="anchor" xlink:href="221_2008_1381_Fig4_HTML" id="MO3"/></fig>
###xml 1002 1005 <span type="species:ncbi:10116">rat</span>
###xml 1231 1234 <span type="species:ncbi:10116">rat</span>
###xml 1554 1558 <span type="species:ncbi:10116">rats</span>
The rostral-caudal distribution of SOM-immunoreactive (-ir) cells within the PeVN was comparable between the sexes and showed a characteristic localization and distribution pattern in relation to the third ventricle (Figs. 3, 4). In the anterior part of the PeVN (sections 1-3) a small, dense population of SOM-ir cells was located just above the suprachiasmatic nucleus (SCN), directly lined along the ventricle wall. Moving more caudally towards the medial part of the PeVN (sections 4-6), a dense population of SOM-ir cells covered the whole length of the third ventricle side area, with maximum numbers of SOM-ir cells at the mid-level (from ventral to dorsal) of the ventricle. Finally, in the posterior part of the PeVN (sections 7-9) small populations of SOM-ir cells were located for the most part along the mid- and dorsal part of the ventricle wall (Fig. 3).Fig. 3SOM cell distribution in the PeVN. Camera lucida drawings of immunoreactive somatostatin cells throughout the PeVN of the adult rat. Cell bodies at the left (female) and right (male) side of the third ventricle are indicated by open circles. These are drawings of the nine successive PeVN sections of one representative OVX + E2 and one representative male rat. III third ventricle; o.c. optic chiasm; SCN suprachiasmatic nucleusFig. 4Average number of SOM cells in the PeVN. Number of SOM-ir cells in the nine successive PeVN sections of male (black bars), OVX female (gray bars), OVX + E2 female (white bars), OVX + P (light gray bars), and OVX + E2 + P female (dark gray bars) rats. Bars represent means +/- SEM. N = 8 for each group. Overall testing revealed significant differences between male and female groups. Significant (P < 0.05) post hoc testing results for individual sections are indicated; males versus all female groups (asterisks) (PeVN sections 1-3, 5-6, 8-9), males versus OVX + E2 and OVX + P (PeVN section 4) (Hash), males versus OVX, OVX + E2, and OVX + P (PeVN section 7) (circle), OVX versus OVX + E2 (PeVN section 4) (cross)
###end p 32
###begin p 33
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 228 240 228 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">III</italic>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o.c.</italic>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCN</italic>
###xml 128 131 <span type="species:ncbi:10116">rat</span>
###xml 357 360 <span type="species:ncbi:10116">rat</span>
SOM cell distribution in the PeVN. Camera lucida drawings of immunoreactive somatostatin cells throughout the PeVN of the adult rat. Cell bodies at the left (female) and right (male) side of the third ventricle are indicated by open circles. These are drawings of the nine successive PeVN sections of one representative OVX + E2 and one representative male rat. III third ventricle; o.c. optic chiasm; SCN suprachiasmatic nucleus
###end p 33
###begin p 34
###xml 110 120 110 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 135 144 135 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bars</italic>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 164 174 164 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bars</italic>
###xml 186 201 186 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">light gray bars</italic>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 229 243 229 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark gray bars</italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bars</italic>
###xml 281 282 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 397 398 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 503 512 501 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisks</italic>
###xml 565 566 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 593 594 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 597 601 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hash</italic>
###xml 629 630 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 662 668 660 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 689 690 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 709 714 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cross</italic>
###xml 245 249 <span type="species:ncbi:10116">rats</span>
Average number of SOM cells in the PeVN. Number of SOM-ir cells in the nine successive PeVN sections of male (black bars), OVX female (gray bars), OVX + E2 female (white bars), OVX + P (light gray bars), and OVX + E2 + P female (dark gray bars) rats. Bars represent means +/- SEM. N = 8 for each group. Overall testing revealed significant differences between male and female groups. Significant (P < 0.05) post hoc testing results for individual sections are indicated; males versus all female groups (asterisks) (PeVN sections 1-3, 5-6, 8-9), males versus OVX + E2 and OVX + P (PeVN section 4) (Hash), males versus OVX, OVX + E2, and OVX + P (PeVN section 7) (circle), OVX versus OVX + E2 (PeVN section 4) (cross)
###end p 34
###begin p 35
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 101 105 <span type="species:ncbi:10116">rats</span>
The total SOM-ir cell number was consistently higher in male compared to ovariectomized (OVX) female rats throughout the PeVN (Fig. 4). The rostro-caudal distribution within the PeVN appeared to be slightly different between the sexes, i.e. maximal SOM-ir cell numbers were found in section 7 in males, but consistently in section 6 in the OVX females, irrespective of gonadal steroid treatment (Fig. 4).
###end p 35
###begin p 36
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 428 429 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
Although in general the rostro-caudal distribution of SOM-ir cells was comparable between different steroid treatment groups, the number of SOM-ir cells appeared to differ between steroid treatments in specific PeVN subregions. E2 or P treatment alone led to a decrease in the number of SOM-ir cells mainly in the anterior and medial parts of the PeVN compared to the untreated OVX females, whereas the combined treatment with E2 and P increased the number of SOM-ir cells particularly in the medial and posterior parts of the PeVN compared to OVX, even though not significantly (Fig. 4).
###end p 36
###begin title 37
Effect of sex and gonadal steroids on SOM cells and SOM-ir area in the PeVN
###end title 37
###begin p 38
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 240 246 240 246 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 344 345 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 385 386 385 386 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bars</italic>
###xml 592 600 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 603 604 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 644 645 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 651 655 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">plus</italic>
###xml 658 659 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 246 680 246 678 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">Effect of gonadal steroids on SOM cells in the PeVN. Total (sections 1&#8211;9) number of SOM-ir cells (<bold>a</bold>) and total (sections 1&#8211;9) SOM-ir area (<bold>b</bold>; reflecting SOM peptide presence) in the PeVN of males and 3&#160;months ovariectomized (OVX3mo) females with different gonadal steroid treatments. <italic>Bars</italic> represent means&#160;&#177;&#160;SEM. Males versus all female groups (<italic>asterisk</italic>) (<italic>P</italic>&#160;=&#160;0.000; ANOVA); OVX&#160;+&#160;P versus OVX&#160;+&#160;E<sub>2</sub>&#160;+&#160;P (<italic>plus</italic>) (<italic>P</italic>&#160;=&#160;0.033; Bonferroni)</p>
###xml 246 680 246 678 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">Effect of gonadal steroids on SOM cells in the PeVN. Total (sections 1&#8211;9) number of SOM-ir cells (<bold>a</bold>) and total (sections 1&#8211;9) SOM-ir area (<bold>b</bold>; reflecting SOM peptide presence) in the PeVN of males and 3&#160;months ovariectomized (OVX3mo) females with different gonadal steroid treatments. <italic>Bars</italic> represent means&#160;&#177;&#160;SEM. Males versus all female groups (<italic>asterisk</italic>) (<italic>P</italic>&#160;=&#160;0.000; ANOVA); OVX&#160;+&#160;P versus OVX&#160;+&#160;E<sub>2</sub>&#160;+&#160;P (<italic>plus</italic>) (<italic>P</italic>&#160;=&#160;0.033; Bonferroni)</p></caption>
###xml 680 680 678 678 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="221_2008_1381_Fig5_HTML" id="MO4"/>
###xml 240 680 240 678 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="39">Effect of gonadal steroids on SOM cells in the PeVN. Total (sections 1&#8211;9) number of SOM-ir cells (<bold>a</bold>) and total (sections 1&#8211;9) SOM-ir area (<bold>b</bold>; reflecting SOM peptide presence) in the PeVN of males and 3&#160;months ovariectomized (OVX3mo) females with different gonadal steroid treatments. <italic>Bars</italic> represent means&#160;&#177;&#160;SEM. Males versus all female groups (<italic>asterisk</italic>) (<italic>P</italic>&#160;=&#160;0.000; ANOVA); OVX&#160;+&#160;P versus OVX&#160;+&#160;E<sub>2</sub>&#160;+&#160;P (<italic>plus</italic>) (<italic>P</italic>&#160;=&#160;0.033; Bonferroni)</p></caption><graphic position="anchor" xlink:href="221_2008_1381_Fig5_HTML" id="MO4"/></fig>
Both the total number of SOM-ir cells and the SOM-ir area (i.e. above-threshold SOM peptide "presence") in the PeVN was significantly higher in males compared to all OVX female groups, irrespective of gonadal steroid treatment (Fig. 5a, b).Fig. 5Effect of gonadal steroids on SOM cells in the PeVN. Total (sections 1-9) number of SOM-ir cells (a) and total (sections 1-9) SOM-ir area (b; reflecting SOM peptide presence) in the PeVN of males and 3 months ovariectomized (OVX3mo) females with different gonadal steroid treatments. Bars represent means +/- SEM. Males versus all female groups (asterisk) (P = 0.000; ANOVA); OVX + P versus OVX + E2 + P (plus) (P = 0.033; Bonferroni)
###end p 38
###begin p 39
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 139 140 139 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bars</italic>
###xml 346 354 344 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 357 358 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 398 399 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 405 409 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">plus</italic>
###xml 412 413 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect of gonadal steroids on SOM cells in the PeVN. Total (sections 1-9) number of SOM-ir cells (a) and total (sections 1-9) SOM-ir area (b; reflecting SOM peptide presence) in the PeVN of males and 3 months ovariectomized (OVX3mo) females with different gonadal steroid treatments. Bars represent means +/- SEM. Males versus all female groups (asterisk) (P = 0.000; ANOVA); OVX + P versus OVX + E2 + P (plus) (P = 0.033; Bonferroni)
###end p 39
###begin p 40
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 147 148 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
E2 or P treatment alone affected neither the total number of SOM-ir cells nor the total SOM-ir area in the PeVN (Fig. 5a, b). Treatment with both E2 and P increased the SOM-ir area, but only significantly when compared to treatment with P alone (Fig. 5b). This effect of combined E2 and P on the number of SOM-ir cells and on the SOM-ir area was most pronounced in the medial and posterior parts of the PeVN, although the differences in each sub-region did not reach statistical significance (data not shown).
###end p 40
###begin title 41
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 60 64 <span type="species:ncbi:10116">rats</span>
Effect of OVX length on SOM cells in the PeVN of E2-treated rats
###end title 41
###begin p 42
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 343 349 343 349 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 472 473 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 476 486 476 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">light bars</italic>
###xml 514 515 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 518 527 518 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark bars</italic>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 608 616 608 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 625 633 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anterior</italic>
###xml 635 636 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 667 668 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 826 827 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 834 835 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 842 843 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 853 861 853 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 349 862 349 862 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43">Effect of OVX length on number of SOM cells. Total number of SOM-ir cells in each PeVN subregion of short-term (&#8220;OVX2wk&#160;+&#160;E<sub>2</sub>&#8221;; <italic>light bars</italic>) and long-term (&#8220;OVX3mo&#160;+&#160;E<sub>2</sub>&#8221;; <italic>dark bars</italic>) ovariectomized rats, treated with E<sub>2</sub>. Short-term versus long-term OVX females (<italic>asterisk</italic>) in the <italic>anterior</italic> (<italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.0004) and medial (<italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.002) PeVN. Insert: total (sections 1&#8211;9) number of SOM-ir cells in the PeVN was significantly higher in long-term compared with short-term OVX&#160;+&#160;E<sub>2</sub> rats. <italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.001 (<italic>asterisk</italic>)</p>
###xml 349 862 349 862 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43">Effect of OVX length on number of SOM cells. Total number of SOM-ir cells in each PeVN subregion of short-term (&#8220;OVX2wk&#160;+&#160;E<sub>2</sub>&#8221;; <italic>light bars</italic>) and long-term (&#8220;OVX3mo&#160;+&#160;E<sub>2</sub>&#8221;; <italic>dark bars</italic>) ovariectomized rats, treated with E<sub>2</sub>. Short-term versus long-term OVX females (<italic>asterisk</italic>) in the <italic>anterior</italic> (<italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.0004) and medial (<italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.002) PeVN. Insert: total (sections 1&#8211;9) number of SOM-ir cells in the PeVN was significantly higher in long-term compared with short-term OVX&#160;+&#160;E<sub>2</sub> rats. <italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.001 (<italic>asterisk</italic>)</p></caption>
###xml 862 862 862 862 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="221_2008_1381_Fig6_HTML" id="MO5"/>
###xml 343 862 343 862 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="43">Effect of OVX length on number of SOM cells. Total number of SOM-ir cells in each PeVN subregion of short-term (&#8220;OVX2wk&#160;+&#160;E<sub>2</sub>&#8221;; <italic>light bars</italic>) and long-term (&#8220;OVX3mo&#160;+&#160;E<sub>2</sub>&#8221;; <italic>dark bars</italic>) ovariectomized rats, treated with E<sub>2</sub>. Short-term versus long-term OVX females (<italic>asterisk</italic>) in the <italic>anterior</italic> (<italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.0004) and medial (<italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.002) PeVN. Insert: total (sections 1&#8211;9) number of SOM-ir cells in the PeVN was significantly higher in long-term compared with short-term OVX&#160;+&#160;E<sub>2</sub> rats. <italic>T</italic>-test, <italic>P</italic>&#160;=&#160;0.001 (<italic>asterisk</italic>)</p></caption><graphic position="anchor" xlink:href="221_2008_1381_Fig6_HTML" id="MO5"/></fig>
###xml 544 548 <span type="species:ncbi:10116">rats</span>
###xml 828 832 <span type="species:ncbi:10116">rats</span>
The total number of SOM-ir cells in the PeVN was significantly lower in long-term (3 months) compared with short-term (2 weeks) ovariectomized females after E2-treatment (Fig. 6; insert). This difference in SOM-ir cell number between long-term and short-term OVX was significant in the anterior and medial, but not in the caudal PeVN (Fig. 6).Fig. 6Effect of OVX length on number of SOM cells. Total number of SOM-ir cells in each PeVN subregion of short-term ("OVX2wk + E2"; light bars) and long-term ("OVX3mo + E2"; dark bars) ovariectomized rats, treated with E2. Short-term versus long-term OVX females (asterisk) in the anterior (T-test, P = 0.0004) and medial (T-test, P = 0.002) PeVN. Insert: total (sections 1-9) number of SOM-ir cells in the PeVN was significantly higher in long-term compared with short-term OVX + E2 rats. T-test, P = 0.001 (asterisk)
###end p 42
###begin p 43
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 127 137 127 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">light bars</italic>
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 169 178 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark bars</italic>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 259 267 259 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 276 284 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anterior</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 294 295 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 504 512 504 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 195 199 <span type="species:ncbi:10116">rats</span>
###xml 479 483 <span type="species:ncbi:10116">rats</span>
Effect of OVX length on number of SOM cells. Total number of SOM-ir cells in each PeVN subregion of short-term ("OVX2wk + E2"; light bars) and long-term ("OVX3mo + E2"; dark bars) ovariectomized rats, treated with E2. Short-term versus long-term OVX females (asterisk) in the anterior (T-test, P = 0.0004) and medial (T-test, P = 0.002) PeVN. Insert: total (sections 1-9) number of SOM-ir cells in the PeVN was significantly higher in long-term compared with short-term OVX + E2 rats. T-test, P = 0.001 (asterisk)
###end p 43
###begin p 44
###xml 116 117 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 157 158 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 287 288 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 325 326 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
In contrast, total SOM-ir area in the PeVN did not differ between long-term and short-term OVX (36,235 +/- 6,531 mum2 for short-term and 23,207 +/- 3,582 mum2 for long-term OVX, respectively), whereas OVX length significantly decreased SOM-ir area in the anterior PeVN (5,628 +/- 810 mum2 for short-term and 2,467 +/- 368 mum2 for long-term OVX, respectively).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 490 493 <span type="species:ncbi:10116">rat</span>
The distribution of SOM cells within the male and female rat PeVN has not been described in great detail previously. Our study clearly shows a sex difference in the periventricular SOM-ir cell distribution. The rostro-caudal distribution being similar, both the relative total number of SOM-ir cells and the SOM-ir area differed markedly between the sexes, with males having significantly more SOM-ir cells and a higher SOM-ir area than OVX females. In addition, we show that in the female rat gonadal steroids modulate SOM peptide immunoreactivity in the PeVN, and that the number of SOM-ir cells is dependent on the period without gonadal steroid hormones (as a result of ovariectomy).
###end p 46
###begin p 47
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">1989</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">1999</xref>
###xml 229 234 229 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">1999a</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">b</xref>
###xml 302 306 <span type="species:ncbi:10116">rats</span>
The higher number of SOM-ir neurons in males compared to females correlates with previous studies also showing higher SOM mRNA levels (Chowen-Breed et al. 1989; Muller et al. 1999) and a higher SOM peptide content (Murray et al. 1999a, b; Nurhidayat et al. 2001) in the PeVN of male compared to female rats.
###end p 47
###begin p 48
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1996</xref>
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 365 366 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">1988</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">1988</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">1990</xref>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 48 52 <span type="species:ncbi:10116">rats</span>
###xml 244 248 <span type="species:ncbi:10116">rats</span>
In our study E2 treatment in OVX (3 mo.) female rats did not have any effect on periventricular SOM-ir area, which is in line with Estupina et al. (1996) who also failed to observe effects of E2 on total hypothalamic SOM peptide content in OVX rats. However, several other studies showed that the effects of OVX on SOM mRNA levels in the PeVN could be reversed by E2 (Baldino et al. 1988; Werner et al. 1988; Zorilla et al. 1990). These data strongly indicate that the effects of E2 on hypothalamic SOM cell activity are controversial and may be different with respect to synthesis, peptide storage and/or release.
###end p 48
###begin p 49
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">1986</xref>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 536 537 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 551 552 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1046 1050 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1990</xref>
###xml 1068 1072 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">1986</xref>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">1989</xref>
###xml 82 85 <span type="species:ncbi:10116">rat</span>
###xml 148 151 <span type="species:ncbi:10116">rat</span>
###xml 664 667 <span type="species:ncbi:10116">rat</span>
The role of P in the regulation of hypothalamic SOM mRNA or peptide in the female rat has not been studied before, as far as we know. Studies using rat anterior pituitary cells show no effects of P on SOM-suppressed GH release (Fukata and Martin 1986), suggesting that P does not affect SOM receptor sensitivity or its expression on somatotrophs. In the present study we found that treatment with the combination of E2 and P slightly increased both the number of SOM-ir cells and the SOM-ir area in the PeVN compared to treatment with E2 (n.s.) or P (P < 0.05) alone, indicating that P may indeed modulate the activity of the hypothalamic SOM system in the female rat. This effect was most pronounced in the medial and posterior PeVN, suggesting that these parts of the PeVN may be more sensitive to gonadal steroids than the anterior part. These observations prompt and support the suggestion of specific subsets of SOM neurons within the PeVN with specific functions with regard to, for instance, the regulation of GH secretion (Argente et al. 1990; Epelbaum et al. 1986; Willoughby et al. 1989).
###end p 49
###begin p 50
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">1991</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">1983</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1996</xref>
###xml 619 620 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">1994</xref>
###xml 675 676 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 790 791 790 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 784 787 <span type="species:ncbi:10116">rat</span>
Although the precise role of gonadal steroids in the regulation of the activity of the periventricular SOM cells remains unclear, SOM synthesis in the hypothalamus and its release from the ME fluctuate during the estrous cycle: SOM mRNA in the PeVN was found to be minimal on the day of diestrus and maximal on the day of proestrus (Zorilla et al. 1991), when SOM peptide levels in the preoptic area, posterior hypothalamus and ME were shown to be low (Knuth et al. 1983). Yet, SOM release from the ME was found to be maximal on the day of proestrus (Estupina et al. 1996), concurrent with cyclic elevations of plasma E2 and P levels (Freeman 1994). These data suggest that E2 or P, and more likely the combination of the two, affects SOM synthesis or release, or both, in the female rat. E2 and P may act synergistically to affect SOM peptide in the PeVN, and the combination of both gonadal hormones may thus be essential for the generation of the typical feminine hypothalamic SOM release pattern.
###end p 50
###begin p 51
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 190 194 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">1993</xref>
###xml 211 215 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2001</xref>
###xml 232 236 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">2003</xref>
###xml 314 318 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2001</xref>
###xml 342 346 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">1997</xref>
###xml 350 351 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 490 494 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">1994</xref>
###xml 587 588 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 614 618 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">1986</xref>
###xml 692 696 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">1994</xref>
###xml 716 720 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR51">1987</xref>
###xml 941 945 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1996</xref>
###xml 963 967 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">1998</xref>
###xml 871 881 <span type="species:ncbi:10141">guinea pig</span>
The effects of E2 and P on periventricular SOM cells are likely to be indirect. First, SOM neurons in the PeVN do not contain E2-receptors alpha (ERalpha) themselves (Herbison and Theodosis 1993; Kamegai et al. 2001; Scanlan et al. 2003), whereas ERbeta expression was not found in the PeVN at all (Kamegai et al. 2001; Simonian and Herbison 1997). E2 may therefore indirectly affect SOM neurons in the PeVN via SOM cells located in nearby hypothalamic areas that contain ERalpha (Herbison 1994), or via GABA-containing neurons in the periventricular regions that have been shown to be E2-receptive (Flugge et al. 1986) and were found to project to SOM cells in the PeVN (Herbison and Augood 1994; Willoughby et al. 1987). Second, to our knowledge, no data exist on the presence of the progesterone-receptor (PR) in SOM cells in the hypothalamus. Although studies in the guinea pig show that SOM cells do contain PR (Dufourny and Warembourg 1996; Dufourny et al. 1998), no co-localization was found in the PeVN, suggesting that also the effect of P on SOM cells in the PeVN is likely to be indirect.
###end p 51
###begin p 52
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 404 405 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 640 641 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 773 776 <span type="species:ncbi:10116">rat</span>
We found that the number of SOM-ir cells in the PeVN was also affected by the time following ovariectomy. Total SOM-ir cell numbers were significantly lower in long-term (3 months) compared to short-term (2 weeks) OVX females that were treated with E2. We did not include a short-term OVX group that was treated with vehicle for this study. However, in a previous study in our lab we found no effect of E2 on the number of SOM-ir cells compared to vehicle-treated animals after short-term OVX (unpublished results, 2001). These data suggest that the number of SOM-ir cells in the female PeVN is also dependent on OVX length rather than on E2 treatment alone. Hence, also P may indeed play an essential role in the regulation of the periventricular SOM system in the female rat.
###end p 52
###begin p 53
The effect of long-term OVX on SOM-ir cells was only significant in the anterior and medial parts of the PeVN, whereas the effects of gonadal steroids were most pronounced in the medial and posterior PeVN. These data again support the hypothesis for different subsets of SOM neurons within the PeVN with specific functions.
###end p 53
###begin p 54
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 127 130 <span type="species:ncbi:10116">rat</span>
###xml 221 224 <span type="species:ncbi:10116">rat</span>
In conclusion, the present study indicates that SOM cell distribution, number of SOM cells, and SOM peptide content within the rat PeVN depend on gender and gonadal steroids. Moreover, our data suggest that in the female rat E2 and P act synergistically to affect SOM cell activity in the PeVN.
###end p 54
###begin p 55
The authors thank Mireille Baart (Wageningen University) for her help with the practical work.
###end p 55
###begin p 56
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Somatostatin messenger RNA in hypothalamic neurons is increased by testosterone through activation of androgen receptors and not by aromatization to estradiol
###end article-title 58
###begin article-title 59
Hormonal regulation of somatostatin messenger RNA
###end article-title 59
###begin article-title 60
Immunocytochemical localization of progestin receptors in monkey hypothalamus: effect of estrogen and progestin
###end article-title 60
###begin article-title 61
Antibodies to small transmitter molecules and peptides: production and application of antibodies to dopamine, seretonin, GABA, vasopressin, vasoactive intestinal peptide, neuropeptide Y, somatostatin and substance P
###end article-title 61
###begin article-title 62
###xml 126 129 <span type="species:ncbi:10116">rat</span>
Sexual dimorphism and testosterone-dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain
###end article-title 62
###begin article-title 63
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 132 136 <span type="species:ncbi:10116">rats</span>
Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats
###end article-title 63
###begin article-title 64
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Growth hormone secretory profiles in conscious female rats
###end article-title 64
###begin article-title 65
Effects of lesions in the periventricular nucleus of the preoptic-anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin
###end article-title 65
###begin article-title 66
###xml 119 129 <span type="species:ncbi:10141">guinea pig</span>
Colocalization of progesterone receptor and somatostatin immunoreactivities in the hypothalamus of the male and female guinea pig
###end article-title 66
###begin article-title 67
###xml 133 143 <span type="species:ncbi:10141">guinea-pig</span>
Multiple peptides infrequently coexist in progesterone receptor- containing neurons in the ventrolateral hypothalamic nucleus of the guinea-pig: an immunocytochemical triple-label analysis of somatostatin, neurotensin and substance P
###end article-title 67
###begin article-title 68
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Age- and sex-related differences in episodic growth hormone secretion in the rat
###end article-title 68
###begin article-title 69
The anterior periventricular hypothalamus is the site of somatostatin inhibition of its own release: an in vitro and immunocytochemical study
###end article-title 69
###begin article-title 70
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Variations in hypothalamic somatostatin release and content during the estrous cycle in the rat. Effects of ovariectomy and estrogen supplementation
###end article-title 70
###begin article-title 71
###xml 100 103 <span type="species:ncbi:10116">rat</span>
Evidence for estrogen-receptive GABAergic neurons in the preoptic/anterior hypothalamic area of the rat brain
###end article-title 71
###begin article-title 72
###xml 55 58 <span type="species:ncbi:10116">rat</span>
The neuroendocrine control of the ovarian cycle of the rat
###end article-title 72
###begin article-title 73
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Influence of sex steroid hormones on rat growth hormone-releasing factor and somatostatin in dispersed pituitary cells
###end article-title 73
###begin article-title 74
Sexual dimorphism of the somatotrophic axis
###end article-title 74
###begin article-title 75
Somatostatin: the neuroendocrine story
###end article-title 75
###begin article-title 76
###xml 129 132 <span type="species:ncbi:10116">rat</span>
Somatostatin-immunoreactive neurones in the hypothalamic ventromedial nucleus possess oestrogen receptors in the male and female rat
###end article-title 76
###begin article-title 77
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Expression of GABAA receptor alpha 2 sub-unit mRNA by periventricular somatostatin neurones in the rat hypothalamus
###end article-title 77
###begin article-title 78
Absence of estrogen receptor immunoreactivity in somatostatin (SRIF) neurons of the periventricular nucleus but sexually dimorphic colocalization of estrogen receptor and SRIF immunoreactivities in neurons of the bed nucleus of the stria terminalis
###end article-title 78
###begin article-title 79
###xml 111 114 <span type="species:ncbi:10116">rat</span>
Immunohistochemical identification of somatostatin-containing neurons projecting to the median eminence of the rat
###end article-title 79
###begin article-title 80
###xml 109 113 <span type="species:ncbi:10116">rats</span>
Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats
###end article-title 80
###begin article-title 81
###xml 103 107 <span type="species:ncbi:10116">rats</span>
Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats
###end article-title 81
###begin article-title 82
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat
###end article-title 82
###begin article-title 83
Sexual dimorphism in the control of growth hormone secretion
###end article-title 83
###begin article-title 84
###xml 120 123 <span type="species:ncbi:10116">rat</span>
Estrogen receptor (ER) alpha, but not ERbeta, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus
###end article-title 84
###begin article-title 85
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Pulsatile somatostatin release from the median eminence of the unanesthetized rat and its relationship to plasma growth hormone levels
###end article-title 85
###begin article-title 86
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat
###end article-title 86
###begin article-title 87
Ghrelin: update on a novel hormonal system
###end article-title 87
###begin article-title 88
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Changes in somatostatin-like activity in discrete areas of the rat hypothalamus during different stages of proestrus and diestrus and their relation to serum gonadotropin, prolactin, and growth hormone levels
###end article-title 88
###begin article-title 89
###xml 185 188 <span type="species:ncbi:10116">rat</span>
Combined retrograde tracing and immunocytochemical identification of luteinizing hormone-releasing hormone- and somatostatin-containing neurons projecting to the median eminence of the rat
###end article-title 89
###begin article-title 90
Neuroendocrine control of growth hormone secretion
###end article-title 90
###begin article-title 91
Correlation of hypothalamic somatostatin mRNA expression and peptide content with secretion: sexual dimorphism and differential regulation by gonadal factors
###end article-title 91
###begin article-title 92
Ontogeny and sexual differentiation of somatostatin biosynthesis and secretion in the hypothalamic periventricular-median eminence pathway
###end article-title 92
###begin article-title 93
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Role of the gonads in sex differentiation of growth hormone- releasing hormone and somatostatin neurons in the mouse hypothalamus during postnatal development
###end article-title 93
###begin article-title 94
###xml 140 143 <span type="species:ncbi:10116">rat</span>
Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat
###end article-title 94
###begin article-title 95
###xml 118 121 <span type="species:ncbi:10116">rat</span>
Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat
###end article-title 95
###begin article-title 96
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Growth hormone secretion after hypothalamic periventricular lesions in the rat
###end article-title 96
###begin article-title 97
Somatostatin-14 neurons in the ovine hypothalamus: colocalization with estrogen receptor alpha and somatostatin-28 (1-12) immunoreactivity, and activation on response to estradiol
###end article-title 97
###begin article-title 98
###xml 100 103 <span type="species:ncbi:10116">rat</span>
Differential expression of estrogen receptor alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular nucleus
###end article-title 98
###begin article-title 99
A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry
###end article-title 99
###begin article-title 100
The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion
###end article-title 100
###begin article-title 101
Interplay of somatostatin and growth hormone-releasing hormone in genesis of episodic growth hormone secretion
###end article-title 101
###begin article-title 102
###xml 83 87 <span type="species:ncbi:10116">rats</span>
Ultradian oscillation in somatostatin binding in the arcuate nucleus of adult male rats
###end article-title 102
###begin article-title 103
###xml 149 153 <span type="species:ncbi:10116">rats</span>
The effects of lateral hypothalamic-medial forebrain stimulation and somatostatin antiserum on pulsatile growth hormone secretion in freely behaving rats: evidence for a dual regulatory mechanism
###end article-title 103
###begin article-title 104
Effects of hypothalamic periventricular lesions on pulsatile growth hormone secretion
###end article-title 104
###begin article-title 105
###xml 201 204 <span type="species:ncbi:10116">rat</span>
Preferential induction of c-fos immunoreactivity in vasoactive intestinal polypeptide-innervated gonadotropin-releasing hormone neurons during a steroid-induced luteinizing hormone surge in the female rat
###end article-title 105
###begin article-title 106
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Steroid regulation of somatostatin mRNA in the rat hypothalamus
###end article-title 106
###begin article-title 107
Ultrastructural evidence for gamma aminobutyric acid- immunoreactive synapses on somatostatin-immunoreactive perikarya in the periventricular anterior hypothalamus
###end article-title 107
###begin article-title 108
Intrahypothalamic actions of somatostatin and growth hormone releasing factor on growth hormone secretion
###end article-title 108
###begin article-title 109
###xml 111 115 <span type="species:ncbi:10116">rats</span>
Ultradian oscillations in somatostatin and growth hormone- releasing hormone mRNAs in the brains of adult male rats
###end article-title 109
###begin article-title 110
###xml 112 115 <span type="species:ncbi:10116">rat</span>
Multihormonal control of pre-pro-somatostatin mRNA levels in the periventricular nucleus of the male and female rat hypothalamus
###end article-title 110
###begin article-title 111
###xml 101 104 <span type="species:ncbi:10116">rat</span>
Variations of pre-prosomatostatin mRNA levels in the hypothalamic periventricular nucleus during the rat estrous cycle
###end article-title 111

